GWMR
RPRX icon

GC Wealth Management RIA’s Royalty Pharma RPRX Stock Holding History

GC Wealth Management RIA’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-7,250
Closed -$256K – 790
2025
Q3 		$256K Buy
+7,250
New +$262K 0.01% 762

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

GC Wealth Management RIA's RPRX Position: Q4 2025 in Review

GC Wealth Management RIA sold out of Royalty Pharma (RPRX) in Q4 2025, closing a stake of 7,250 shares — an estimated $256K sold.

GC Wealth Management RIA first reported a position in RPRX in Q3 2025 and held it in 1 quarter. The position peaked at $256K in Q3 2025. 540 funds tracked by Wall St. Rank hold RPRX as of Q4 2025.

  • GC Wealth Management RIA reported no remaining Royalty Pharma position as of Q4 2025 after selling out during the quarter.
  • GC Wealth Management RIA sold 7,250 Royalty Pharma shares in Q4 2025, an estimated $256K.
  • GC Wealth Management RIA first reported a position in Royalty Pharma in Q3 2025 and held it in 1 quarter.
  • GC Wealth Management RIA's Royalty Pharma position peaked at $256K in Q3 2025.
  • 540 funds tracked by Wall St. Rank held Royalty Pharma as of Q4 2025.

Based on GC Wealth Management RIA's 13F filing for Q4 2025, filed 30 Jan 2026.